[Discussion on the curative effect and mechanisms of berberine in rats with non-alcoholic fatty liver].

Li, D H; Liu, Y T; Hao, S R; Zheng, J M; Hou, H T; Wang, Y Z

Li, D H; Liu, Y T; Hao, S R; Zheng, J M; Hou, H T; Wang, Y Z.

Afiliación

Li DH; Department of Gastroenterology, Affiliated Hospital of Hebei University of Engineering, Handan 056002, China.
Liu YT; Department of Pain Medicine, Hebei General Hospital, Shijiazhuang 050051, China.
Hao SR; Department of Infectious Diseases, Handan No.7 Hospital, Handan 056001, China.
Zheng JM; Department of Gastroenterology, Hebei General Hospital, Shijiazhuang 050051, China.
Hou HT; Department of Gastroenterology, Hebei General Hospital, Shijiazhuang 050051, China.
Wang YZ; Department of Gastroenterology, Hebei General Hospital, Shijiazhuang 050051, China.

Zhonghua Gan Zang Bing Za Zhi ; 28(4): 338-344, 2020 Apr 20.

Article en Zh | MEDLINE | ID: mdl-32403887

Asunto(s)

Berberina/uso terapéutico; Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico; Animales; Dieta Alta en Grasa; Hígado; Distribución Aleatoria; Ratas; Ratas Sprague-Dawley

Palabras clave

Berberine; Endotoxemia; Fatty liver, non-alcoholic; Fecal microbiota

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Berberina / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google